🚀 VC round data is live in beta, check it out!

Aemetis Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aemetis and similar public comparables like Avantium, Gurit Holding, Trayal Korporacija, Aspo and more.

Aemetis Overview

About Aemetis

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.


Founded

2006

HQ

United States

Employees

223

Sectors

Financials (LTM)

Revenue: $246M
EBITDA: ($6M)

EV

$592M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Aemetis Financials

Aemetis reported last 12-month revenue of $246M and negative EBITDA of ($6M).

In the same LTM period, Aemetis generated $16M in gross profit, ($6M) in EBITDA losses, and had net loss of ($76M).

Revenue (LTM)


Aemetis P&L

In the most recent fiscal year, Aemetis reported revenue of $208M and EBITDA of ($20M).

Aemetis is unprofitable as of last fiscal year, with gross margin of (0%), EBITDA margin of (10%), and net margin of (37%).

See analyst estimates for Aemetis
LTMLast FY202320242025202620272028
Revenue$246M$208M$187M$268M$208M
Gross Profit$16M($768K)$2M($580K)($768K)
Gross Margin7%(0%)1%(0%)(0%)
EBITDA($6M)($20M)($35M)($37M)($32M)
EBITDA Margin(2%)(10%)(19%)(14%)(15%)
EBIT Margin(9%)(18%)(20%)(15%)(18%)
Net Profit($76M)($77M)($46M)($88M)($77M)
Net Margin(31%)(37%)(25%)(33%)(37%)
Net Debt—$377M———

Financial data powered by Morningstar, Inc.

Aemetis Stock Performance

Aemetis has current market cap of $215M, and enterprise value of $592M.

Market Cap Evolution


Aemetis' stock price is $3.16.

Aemetis share price increased by 84.8% in the last year.

Aemetis has an EPS (earnings per share) of $-1.13.

See more trading valuation data for Aemetis
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$592M$215M6.8%—122.5%84.8%$-1.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Aemetis Valuation Multiples

Aemetis trades at 2.4x EV/Revenue multiple, and (102.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Aemetis

EV / Revenue (LTM)


Aemetis Financial Valuation Multiples

As of May 1, 2026, Aemetis has market cap of $215M and EV of $592M.

Aemetis has a P/E ratio of (2.8x).

LTMLast FY202320242025202620272028
EV/Revenue2.4x2.8x3.2x2.2x2.8x
EV/EBITDA(102.7x)(29.4x)(17.0x)(16.0x)(18.7x)
EV/EBIT(26.0x)(15.9x)(15.8x)(14.7x)(15.9x)
EV/Gross Profit36.2xn/mn/mn/mn/m
P/E(2.8x)(2.8x)(4.6x)(2.5x)(2.8x)
EV/FCF—(26.0x)(30.7x)(11.1x)(26.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Aemetis Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Aemetis Margins & Growth Rates

Aemetis grew revenue by 55% but EBITDA decreased by 215% in the last fiscal year.

In the most recent fiscal year, Aemetis reported gross margin of (0%), EBITDA margin of (10%), and net margin of (37%).

See estimated margins and future growth rates for Aemetis

Aemetis Margins

Last FY202420252026202720282029
Gross Margin(0%)(0%)(0%)14%
EBITDA Margin(10%)(14%)(15%)7%
EBIT Margin(18%)(15%)(18%)2%
Net Margin(37%)(33%)(37%)(23%)
FCF Margin(11%)(20%)(11%)(86%)

Aemetis Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth55%43%(22%)55%
Gross Profit Growth(5814%)(129%)32%(5814%)
EBITDA Growth(215%)7%(15%)(173%)
EBIT Growth(117%)8%(8%)(117%)
Net Profit Growth(2%)89%(12%)(2%)
FCF Growth1118%176%(57%)1118%

Data powered by FactSet, Inc. and Morningstar, Inc.

Aemetis Operational KPIs

Aemetis' revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.

Aemetis' Rule of 40 is 62% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Aemetis' Rule of X is 144% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Aemetis
LTMLast FY202320242025202620272028
Rule of 4050%62%———
Bessemer Rule of X129%144%———
Revenue per Employee—$0.9M———
Opex per Employee—$0.2M———
R&D Expenses to Revenue0%0%0%—0%
Opex to Revenue—18%21%15%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Aemetis Competitors

Aemetis competitors include Avantium, Gurit Holding, Trayal Korporacija, Aspo, H&R Gruppe, Grupa Azoty Puławy, Solar Foods, XRF Scientific, Exel Industries and Dexxos.

Most Aemetis public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Avantium16.4x11.0x(15.9x)(9.0x)
Gurit Holding0.7x0.7x(25.5x)39.5x
Trayal Korporacija2.7x—69.1x—
Aspo0.7x0.7x5.4x5.7x
H&R Gruppe0.2x0.2x3.4x3.4x
Grupa Azoty Puławy0.2x—15.4x—
Solar Foods1357.5x194.9x(178.7x)116.4x
XRF Scientific4.2x3.9x15.1x14.6x

This data is available for Pro users. Sign up to see all Aemetis competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Aemetis

When was Aemetis founded?Aemetis was founded in 2006.
Where is Aemetis headquartered?Aemetis is headquartered in United States.
How many employees does Aemetis have?As of today, Aemetis has over 223 employees.
Who is the CEO of Aemetis?Aemetis' CEO is Eric A. McAfee.
Is Aemetis publicly listed?Yes, Aemetis is a public company listed on Nasdaq.
What is the stock symbol of Aemetis?Aemetis trades under AMTX ticker.
When did Aemetis go public?Aemetis went public in 1990.
Who are competitors of Aemetis?Aemetis main competitors include Avantium, Gurit Holding, Trayal Korporacija, Aspo, H&R Gruppe, Grupa Azoty Puławy, Solar Foods, XRF Scientific, Exel Industries, Dexxos.
What is the current market cap of Aemetis?Aemetis' current market cap is $215M.
What is the current revenue of Aemetis?Aemetis' last 12 months revenue is $246M.
What is the current revenue growth of Aemetis?Aemetis revenue growth (NTM/LTM) is 52%.
What is the current EV/Revenue multiple of Aemetis?Current revenue multiple of Aemetis is 2.4x.
Is Aemetis profitable?No, Aemetis is not profitable.
What is the current EBITDA of Aemetis?Aemetis has negative EBITDA and is not profitable.
What is Aemetis' EBITDA margin?Aemetis' last 12 months EBITDA margin is (2%).
What is the current EV/EBITDA multiple of Aemetis?Current EBITDA multiple of Aemetis is (102.7x).
How many companies Aemetis has acquired to date?Aemetis hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Aemetis has invested to date?Aemetis hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Aemetis

Lists including Aemetis

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial